Veeva Systems Stock News

Veeva Systems' (VEEV) product gets adopted by CBM. This can drive the development and delivery of groundbreaking treatments for patients.

Veeva Systems Inc. (NYSE:VEEV) Director Matthew J. Wallach sold 5,000 shares of the firms stock in a transaction that occurred on Friday, November 12th. The stock was sold at an average price of $316.25, for a total transaction of $1,581,250.00. The transaction was disclosed in a document filed with the SEC, which can be accessed []

NEW YORK , Nov. 16, 2021 /PRNewswire/ -- Telehealth seems to be going strong with no signs of slowing down in the post-pandemic era. As telehealth companies develop programs to support online care, insurance companies like Humana have developed affordable healthcare plans for those seeking online healthcare. In addition to supporting telehealth, these companies are seeing an increase in the adoption of digital healthcare and cost savings associated with the same. Meanwhile, telehealth companies such as CloudMD Software & Services Inc. (TSXV: DOC ) (OTCPK: DOCRF), Veeva Systems, Inc. (NYSE: VEEV ), 1LifeHealthcare, Inc. (NASDAQ: ONEM ), Teladoc Health (NYSE: TDOC ), and Allscripts Healthcare Solutions Inc. (NASDAQ: MDRX ) are engaging in various initiatives to make digital healthcare available to more patients and tap into the market opportunities telehealth creates. CloudMD Software & Services Inc. (TSXV: DOC ) (OTC: DOCRF) has continued to expand its reach across North America and beyond via strategic acquisitions.

Veeva Systems (VEEV) closed the most recent trading day at $315.54, moving -0.67% from the previous trading session.

Expanded datasets will help biopharmaceutical companies reach new customers and support more personalized engagement Veeva Systems announced it will expand Veeva OpenData customer reference data across Europe to connect new email, demographic, and public claims data across the full spectrum of key healthcare stakeholders. By bringing more data into Veeva CRM, OpenData helps biopharma The post Veeva Launches European Reference Data for the Complete Healthcare Ecosystem appeared first on iTechnology Series .

Expanded datasets will help biopharmaceutical companies reach new customers and support more personalized engagement BARCELONA, Spain, Nov. 15, 2021 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) toda

PLEASANTON, Calif., Oct. 13, 2021 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced the TMF Bot, a new Veeva Vault eTMF feature that uses artificial intelligence (AI) to streamline TMF manag

For those focused on the long game, the recent poor stock performances of Vertex Pharmaceuticals and Veeva Systems may present buying opportunities.

Veeva Systems' (VEEV) solution gets adopted by Celerion in a bid to boost paperless clinical trials.

This company is making it easier than ever for restaurants to manage their business.

Veeva was ranked second in my Landslide Portfolio due to strong financial success and growth prospects. Since I calculated valuation and expected return, the stock price has fallen over 10%, and so, I

PLEASANTON, Calif., Oct. 6, 2021 /PRNewswire/ -- Veeva Systems (NYSE: VEEV) today announced that Celerion adopted Veeva eConsent, a MyVeeva for Patients solution, to complete electronic consent for

The future looks bright with these two supercharged stocks.

From clinical trials to the patient experience, these mobile app developers could change the nature of healthcare.

Veeva (VEEV) reported earnings 30 days ago. What's next for the stock?